HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Unilever Cosmetics management

This article was originally published in The Rose Sheet

Executive Summary

Laura Klauberg appointed senior VP Marketing of Unilever Cosmetics International, overseeing marketing initiatives for company's three designer prestige fragrance divisions: Calvin Klein Cosmetics, Unilever Prestige and European Designer Parfums. Klauberg, a 20-year veteran of Unilever who most recently worked as skin care brand development VP in North America, will succeed three global marketing heads - Unilever Prestige President Laura Lee Miller, Calvin Klein President Hilary Dart and European Designer Parfums President Gabrielle Pungerscheg, who have left the company. New structure will unite the global marketing efforts for all three divisions under one head and create a more focused program, Unilever says. Klauberg will report directly to UCI President and CEO Kevin Boyce...

You may also be interested in...



Calvin Klein Signs Actress Johansson As Face Of New Women’s Fragrance

Calvin Klein Cosmetics has signed actress Scarlett Johansson as the face of a new fragrance positioned to appeal to younger women, the Unilever Cosmetics International division announced Feb. 17

Unilever Cosmetics International Innovation Revival Underway

Unilever Cosmetics International is stepping up innovation under new management to boost sales of the prestige fragrance unit, VP-Investor Relations Howard Green said during an Oct. 29 Q3 sales and earnings call

QUOTED. 26 February 2020. Mark Leahey.

In an exclusive interview with Medtech Insight, Mark Leahey, president of the Medical Device Manufacturers Association (MDMA), said the previous four Medical Device User Fee negotiations with the US FDA have set a strong foundation for the industry and the next round of negotiations should focus on tweaking past deals that are already in place. See what MDMA's president, Mark Leahey, said about it here.

UsernamePublicRestriction

Register

RS011586

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel